HEAL Africa Hospital, Goma, Democratic Republic of Congo Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2014
NCT02102321
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

HEAL Hospital, DRC

Active Ingredients

Drugs in Phase 2 Trials (1)

artemisia (1 trial)

Drugs in Other Trials (1)

albendazole (Albenza) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2